CRBP icon

Corbus Pharmaceuticals
CRBP

Overview Fund Activity

27 hedge funds and large institutions have $5.01M invested in Corbus Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
4
Closed
3
Calls
$239K
Puts
$4K
Net Calls
+$235K
Net Calls Change
-$40K

Top Buyers

1
Geode Capital Management
1
Geode Capital Management
Massachusetts
$251K
2
BFM
2
Boothbay Fund Management
New York
$280K
3
IC
3
Ikarian Capital
Texas
$1.32M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$11.5K
5
UBS Group
5
UBS Group
Switzerland
$7.97K

Top Sellers

1
DWA
1
Dorsey Wright & Associates
California
$0
2
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$197K
3
BlackRock
3
BlackRock
New York
$547K
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$9K
5
TRCT
5
Tower Research Capital (TRC)
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Comerica Bank
26
Comerica Bank
Texas
$7 1 +1 New
DWA
27
Dorsey Wright & Associates
California
– – -2,555 Closed
TRCT
28
Tower Research Capital (TRC)
New York
– – -147 Closed
Bank of America
29
Bank of America
North Carolina
– – -1 Closed
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
– – – –
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
NS
32
NBC Securities
Alabama
$0 33 +33 New
1
2